多囊卵巢综合征血脂代谢与胰岛素抵抗的关系探讨

目的：探讨多囊卵巢综合征患者的血脂代谢与胰岛素抵抗的关系。方法：选取2012年1～12月在我院进行多囊卵巢综合征治疗的60例患者作为研究对象,回顾性分析所有患者的临床资料,观察患者的血脂异常与胰岛素抵抗的关系。结果：多囊卵巢综合征患者胰岛素抵抗的发生率为75.00%,与非胰岛素抵抗的患者相比,具有明显差异;多囊卵巢综合征患者总体血脂代谢异常的发生率为83.33%,抵抗组血脂异常发生率为25.00%,非胰岛素抵抗组为58.33%,组间具有明显差异,P＜0.05,具有统计学意义。结论：在临床治疗中,多囊卵巢综合征患者的血脂代谢与胰岛素抵抗的发生率一般较高,血脂代谢异常与胰岛素抵抗呈正比。

Cystic ovarian syndrome to explore the relationship between blood lipid metabolism and insulin resistance

Objective: To investigate the relationship between lipid metabolism and insulin resistance in patients with polycystic ovary syndrome. Methods: January 2012 ~ December 2012 in our hospital for treatment of polycystic ovary syndrome in 60 patients for the study, a retrospective analysis of clinical data for all patients, compare observed in patients with dyslipidemia and insulin resistance relationship. Results: polycystic ovary syndrome Insulin resistance was 75.00%, compared with patients with non-insulin resistance, with significant differences; the overall lipid metabolism in patients with polycystic ovary syndrome abnormal incidence of 83.33%, resistance group was 25.00% abnormal blood lipids, lipid metabolism abnormality non-insulin resistant group was 58.33%, with a significant difference between the two groups, P<0.05, with statistical significance. Conclusions: In clinical treatment, the incidence of polycystic ovary syndrome lipid metabolism and insulin resistance in patients with generally higher, abnormal lipid metabolism and insulin resistance is proportional.